CLBT
Cellebrite DI Ltd.
Set alert
- YTD
- -32.61%
- 1 year
- -29.24%
- Open
- 12.24
- Prev close
- 12.28
- Mkt cap
- 3.05B
- Vol
- 1.74M
- Avg vol
- 3.01M
- EPS
- 0.23
- P/E
- 52.83
- Div yield
- 0.00%
More statistics
- Low
- 12.02
- High
- 12.27
- Forward P/E
- 18.60
- Beta
- 1.13
- Short ratio
- 2.90
- Inst. own
- 53.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 11.48
- 200-d avg
- 13.43
- 1y target
- 15.36
Key statistics
- Market cap
- 3.05B
- Enterprise value
- 2.66B
- Trailing P/E
- 52.83
- Forward P/E
- 18.60
- PEG ratio
- 0.00
- Price / sales
- 5.94
- Price / book
- 5.66
- EPS (TTM)
- 0.23
- Beta
- 1.13
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 11.43%
- Revenue (TTM)
- 514.29M
- Revenue growth
- 15.80%
- Free cash flow
- 124.92M
- Total cash
- 442.53M
- Total debt
- 23.23M
- Return on equity
- 12.42%
- Shares outstanding
- 251.34M
- Short % of float
- 5.10%
- 50-day average
- 11.48
- 200-day average
- 13.43
Analyst view
Consensus: none
- Target (low)
- 12.50
- Target (mean)
- 15.36
- Target (high)
- 20.00
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 12, 2026
Expected Nov 12, 2026. Consensus EPS estimate 0.15808.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sep 30, 2026 | 0.09404 | — | — | — |
| Aug 13, 2026 | Jun 30, 2026 | 0.05939 | 0.0257 | -0.03 | -56.73% |
| May 14, 2026 | Mar 31, 2026 | 0.05377 | 0.04 | -0.01 | -25.61% |
| Feb 11, 2026 | Dec 31, 2025 | 0.14 | 0.0867 | -0.05 | -38.07% |
| Nov 12, 2025 | Sep 30, 2025 | 0.09449 | 0.08 | -0.01 | -15.33% |
| Aug 14, 2025 | Jun 30, 2025 | 0.10 | 0.12 | +0.02 | +20.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 2026 | DA Davidson | main | Buy | Buy |
| Aug 14, 2026 | Lake Street | main | Buy | Buy |
| Aug 14, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 14, 2026 | DA Davidson | main | Buy | Buy |
| Aug 14, 2026 | Needham | main | Buy | Buy |
| Aug 6, 2026 | DA Davidson | main | Buy | Buy |
About Cellebrite DI Ltd.
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
- Sector
- Technology
- Industry
- Software - Infrastructure
- Country
- Israel
- Website
- cellebrite.com
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
- Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT
- Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026
- Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
- Cellebrite DI (NASDAQ:CLBT) CFO David Barter Sells 12,134 Shares of Company Stock
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT
- Kaplan Fox Shareholder Alert: Cellebrite DI Ltd. (CLBT) is Under Investigation for Possible Securities Law Violations
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT
Your note
Sign in to keep a note on CLBT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARTER DAVID | Chief Financial Officer | Sale | Oct 15, 2026 | 322,085 |
| BAUDOT-TRAJTENBERG NADINE PH.D. | Director | Stock Award(Grant) | Sep 16, 2026 | 50,744 |
| CLAMMER ADAM H | Director | Stock Award(Grant) | Sep 16, 2026 | 14,697,600 |
| DOMNITZ YONATAN | Director | Stock Award(Grant) | Sep 16, 2026 | 86,586 |
| GEE DAVID NICHOLAS | Officer | Sale | Aug 23, 2026 | 135,281 |
| GRUBER DAFNA EYAL | Director | Stock Award(Grant) | Sep 16, 2026 | 43,109 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| True Wind Capital Management, L.P. | 5.56% | 13,861,007 | 168.41M | Sep 29, 2026 |
| Voss Capital, LP | 4.59% | 11,441,874 | 139.02M | Jun 29, 2026 |
| Pertento Partners LLP | 3.21% | 8,004,867 | 97.26M | Jun 29, 2026 |
| Phoenix Financial Ltd. | 2.48% | 6,181,269 | 75.10M | Jun 29, 2026 |
| FMR, LLC | 2.39% | 5,971,666 | 72.56M | Jun 29, 2026 |
| Blackrock Inc. | 2.28% | 5,684,040 | 69.06M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 1.63% | 4,057,763 | 49.30M | Sep 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 0.83% | 2,066,932 | 25.11M | Aug 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 0.56% | 1,397,027 | 16.97M | Jul 30, 2026 |
| Central Securities Corporation | 0.52% | 1,300,000 | 15.79M | Jun 29, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 0.52% | 1,301,013 | 15.81M | Jul 30, 2026 |
| Fidelity Advisor Series I-Fidelity Advisor Small Cap Fund | 0.40% | 995,800 | 12.10M | Aug 30, 2026 |